ArticleNeuro-oncology2024

Targeting HTR2B suppresses nonfunctioning pituitary adenoma growth and sensitizes cabergoline treatment via inhibiting Gαq/PLC/PKCγ/STAT3 axis.

Shaojian Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.